581 filings
Page 9 of 30
6-K
7x6 1b9qzrk0
6 Nov 18
Current report (foreign)
4:15pm
6-K
sxuqlti psuriq
6 Nov 18
Current report (foreign)
8:01am
6-K
pnvv4jy88ye46
1 Nov 18
Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen™ in United States and Canada
8:01am
6-K
xl8az1ivvg y8u
31 Oct 18
Current report (foreign)
4:05pm
6-K
i3f tz1fm
2 Oct 18
for the Month of October 2018
4:59pm
6-K
wj9hvzv
25 Sep 18
Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer
8:01am
6-K
f96qbepknjbp5uicblm8
9 Aug 18
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
4:23pm
6-K
27cnf p5gz5w
9 Aug 18
Condensed Interim Consolidated Financial Statements
12:00am
6-K
5tok9av2
2 Aug 18
Current report (foreign)
4:05pm
6-K
mpd45sl
31 May 18
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
4:16pm
6-K
eg5ul68xciaj213
8 May 18
Report as to Voting Results
5:02pm
6-K
ecuj2kexfk m359s7
8 May 18
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
4:19pm
6-K
6r9m8 3khlv7d441ir7
7 May 18
Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results
4:15pm
6-K
0xe9gme8kn4ucomwm
7 May 18
Condensed Interim Consolidated Financial Statements
4:02pm
6-K
nzd1qc7hp73t
1 May 18
Current report (foreign)
5:10pm
6-K
oet n7oomt0v
9 Apr 18
Current report (foreign)
12:00am
6-K
w8tfdzrh69c0nn71uv
9 Apr 18
Annual and Special Meeting of Shareholders
12:00am
6-K
o6gdo 6ymlx9
28 Mar 18
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results
12:00am
6-K
79k mi78sr7snx
28 Mar 18
Current report (foreign)
12:00am
6-K/A
p7np8b bjiwx6
28 Mar 18
Current report (foreign) (amended)
12:00am